LSK Technologies

LSK Technologies Inc. provides a disruptive platform capable of conducting nucleic acid and protein testing on multiple samples at any time, generating results within 30 minutes while providing real-time access to laboratory-grade results. The first version of the device, named PLUM, was deployed in remote Latin American communities to address the threat of the Zika virus. When the COVID-19 pandemic broke out, the company quickly expanded their platform to detect SARS-CoV-2.